10x Genomics, Inc. — Form 8-K
Filed November 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Form 8-K filed 2 Nov 2026 (period 28 Oct 2026) under Item 5.02 concerning departure of directors/officers or appointment/compensation. The filing document list and EDGAR metadata provided contain no substantive disclosure text—specific names, dollar amounts, dates, titles, or nature of changes are not present in the supplied materials.
Why this rating
Without concrete details (officer name, role, departure date, severance, equity), cannot assess materiality. Standard officer change disclosure; routine if junior; potentially significant only if C-suite.
Extracted items
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.